Furthermore, we demonstrated that 5-hydroxytryptamine receptor 2A (HTR2A) fosters the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling [10]. Here, AKT1 is linked to cardiac hypertrophy.